23 February 2018
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics reports that 5-aminosalicylates are frequently used for the treatment of Crohn's disease.
There is uncertain evidence of effectiveness of 5-aminosalicylates (5-ASA) to induce and maintain
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors